Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130073 · ClinicalTrials.gov registry record
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 41
- Enrollment target
NCT05130073: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT05130073 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130073 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- OTHER Electronic Health Record Review
- PROCEDURE Follow-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2023-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05130073
The ClinicalTrials.gov registry entry for NCT05130073 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Computed Tomography is the first listed.
NCT05130073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05130073 about?
NCT05130073 is a clinical study titled "4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer". This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer res...
What is the current status of trial NCT05130073?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2019-07-31. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT05130073?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Electronic Health Record Review (OTHER), Follow-Up (PROCEDURE).
Who is sponsoring clinical trial NCT05130073?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.